Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia

被引：0
|
作者：
Ureshino, Hiroshi [1 ,2 ,3 ]
Watanabe, Tatsuro [2 ]
Kimura, Shinya [1 ,2 ]
机构：
[1] Saga Univ, Dept Hematol & Oncol, Saga, Japan
[2] Saga Univ, Dept Drug Discovery & Biomed Sci, Saga, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Higashihiroshima, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1006
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] Venetoclax in adult acute myeloid leukemia
    Hu, Mengci
    Li, Wenzhe
    Zhang, Youshan
    Liang, Caixia
    Tan, Jie
    Wang, Ya
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [22] Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
    Fleischmann, Maximilian
    Jentzsch, Madlen
    Brioli, Annamaria
    Eisele, Florian
    Frietsch, Jochen J.
    Eigendorff, Farina
    Tober, Romy
    Schrenk, Karin G.
    Hammersen, Jakob Friedrich
    Yomade, Olaposi
    Hilgendorf, Inken
    Hochhaus, Andreas
    Scholl, Sebastian
    Schnetzke, Ulf
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 285 - 294
  • [23] Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients
    Chatzikalil, Elena
    Roka, Kleoniki
    Diamantopoulos, Panagiotis T.
    Rigatou, Efthymia
    Avgerinou, Georgia
    Kattamis, Antonis
    Solomou, Elena E.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [24] OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
    Wilde, Lindsay
    Martinez-Outschoorn, Ubaldo
    Palmisiano, Neil
    Kasner, Margaret
    BLOOD, 2019, 134
  • [25] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    BLOOD, 2020, 136
  • [26] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [27] The Effect and Mechanism of Venetoclax in Combination with SAR405 in Acute Myeloid Leukemia
    Li, Youhong
    Jiang, Xia
    Jiang, Lei
    Lu, Ying
    Jin, Jie
    Pei, Renzhi
    BLOOD, 2024, 144 : 5816 - 5817
  • [28] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [29] Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
    Griffioen, Mila S.
    de Leeuw, David C.
    Janssen, Jeroen J. W. M.
    Smit, Linda
    CANCERS, 2022, 14 (14)
  • [30] Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse
    Bae, Soyoung
    Sa, Seungwon
    Park, Silvia
    Cho, Byung-Sik
    Kim, Hee-Je
    ACTA HAEMATOLOGICA, 2023, : 352 - 359
12345